Community-acquired Pneumonia
📧 Sign up to get email alerts when something new happens for Community-acquired Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-03-28Clinical Trial Update: A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS [Phase 2]
The Phase 2 pharmacokinetics and safety study of Augmentin ES-600 in children with community-acquired pneumonia and acute bacterial rhinosin…
-
CLINICAL_TRIALS withdrawal · 2020-06-04Clinical Trial Update: EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA [Phase 3]
Phase 3 trial evaluating hydroxychloroquine plus azithromycin for prevention of COVID-19–related ARDS was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-25Clinical Trial Update: Clinical Pediatric Pneumonia Score in Critically Ill Children
Clinical trial evaluating a pediatric pneumonia severity score in critically ill children has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-04-19Clinical Trial Update: Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP [NA]
A University of Pittsburgh trial evaluating microbiology-guided antimicrobial therapy for community-acquired pneumonia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-02-29Clinical Trial Update: Corticosteroids in Community-acquired Pneumonia [NA]
The clinical trial investigating corticosteroids for community-acquired pneumonia has been withdrawn from ClinicalTrials.gov.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2016-02-03Clinical Trial Update: Procalcitonin Versus C-reactive Protein to Guide Therapy in Community Acquired Pneumonia [NA]
A clinical trial comparing procalcitonin and C-reactive protein to guide therapy in community-acquired pneumonia was withdrawn. No results w…
-
CLINICAL_TRIALS withdrawal · 2016-01-22Clinical Trial Update: A P3 Comparator Trial in Community Acquired Bacterial Pneumonia [Phase 3]
A Phase 3 comparator trial for community-acquired pneumonia sponsored by Durata Therapeutics (an Allergan affiliate) was withdrawn, with no …
-
CLINICAL_TRIALS withdrawal · 2015-04-22Clinical Trial Update: Impact of Statins on Cytokine Expression in Pneumonia [Phase 4]
Phase 4 clinical trial evaluating the impact of statins on cytokine expression in community-acquired pneumonia was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-02-22Clinical Trial Update: Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia [Phase 3]
A Phase 3 trial comparing tigecycline to ceftriaxone for complicated intra-abdominal infection and community-acquired pneumonia has been wit…
-
CLINICAL_TRIALS withdrawal · 2012-06-07Clinical Trial Update: Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia [Phase 3]
A Phase 3 trial evaluating tigecycline versus ceftriaxone for complicated intra-abdominal infections and community-acquired pneumonia has be…